2013
DOI: 10.1111/pcmr.12058
|View full text |Cite
|
Sign up to set email alerts
|

RhoJ modulates melanoma invasion by altering actin cytoskeletal dynamics

Abstract: Summary Rho family GTPases regulate diverse processes in human melanoma ranging from tumor formation to metastasis and chemoresistance. In this study, a combination of in vitro and in vivo approaches was utilized to determine whether RHOJ, a CDC42 homologue that regulates melanoma chemoresistance, also controls melanoma migration. Depletion or overexpression of RHOJ altered cellular morphology, implicating a role for RHOJ in modulating actin cytoskeletal dynamics. RHOJ depletion inhibited melanoma cell migrati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
30
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(35 citation statements)
references
References 37 publications
3
30
0
Order By: Relevance
“…Interestingly, RhoJ and Arl4D were validated as genes differentially regulated between C57 and Cav-1 KO and are both implicated in actinmediated cell migration (47,48). Furthermore, Cxcr4 was also validated as a differentially regulated gene and is implicated in dopaminergic cell migration (49).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, RhoJ and Arl4D were validated as genes differentially regulated between C57 and Cav-1 KO and are both implicated in actinmediated cell migration (47,48). Furthermore, Cxcr4 was also validated as a differentially regulated gene and is implicated in dopaminergic cell migration (49).…”
Section: Discussionmentioning
confidence: 99%
“…This is the first report of p41ARC serving as a downstream effector of PAK1 signaling in skeletal muscle cells. PAK1 has been shown to phosphorylate p41ARC in vitro, in MCF-7 cancer cells upon EGF stimulation (24,26), and in melanoma cells (25). p41ARC is one of two principle ARP2/3 subunits, the other and more commonly used subunit being ARPC1A (40).…”
Section: Cytoskeletal Regulation Of Skeletal Muscle Glucose Uptakementioning
confidence: 99%
“…TCL suppression in these experiments inhibited pro-angiogenic vessel infiltration of tumors and promoted a loss of vessel integrity within the tumor mass (10). TCL expression and activity has also been implicated in metastatic melanomas, conferring both chemo-resistance and enhanced motility to the cancer cells (11,12). These unique niches of TCL activity suggest it is a strong candidate for directed chemotherapy, with few anticipated off-target effects, particularly as TCL knock-out mice show little phenotypic impairments except minor defects in corneal development (10,13).…”
Section: Tcl/rhoj Was First Characterized About 15 Years Ago As a Rhomentioning
confidence: 82%